196 related articles for article (PubMed ID: 25759829)
1. Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.
Kyriakou A; Patsatsi A; Vyzantiadis TA; Sotiriadis D
J Immunol Res; 2014; 2014():467541. PubMed ID: 25759829
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of TNF- α , IL-12/23 p40, and IL-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study.
Kyriakou A; Patsatsi A; Vyzantiadis TA; Sotiriadis D
ScientificWorldJournal; 2014; 2014():508178. PubMed ID: 25614889
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine measurements and biological therapy of psoriasis - Prospects for personalized treatment?
Solberg SM; Sandvik LF; Eidsheim M; Jonsson R; Bryceson YT; Appel S
Scand J Immunol; 2018 Dec; 88(6):e12725. PubMed ID: 30307657
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
[TBL] [Abstract][Full Text] [Related]
5. Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report.
Brito-Luna MJ; Villanueva-Quintero DG; Sandoval-Talamantes AK; Fafutis-Morris M; Graciano-Machuca O; Sanchez-Hernandez PE; Alvarado-Navarro A
Cytokine; 2016 Sep; 85():130-6. PubMed ID: 27344023
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
Jacob SE; Nassiri M; Kerdel FA; Vincek V
Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tumour necrosis factor (TNF-α) and interleukin-17 (IL-17) in patients with nail psoriasis: A cross-sectional study.
Bhoi AK; Grover C; Singal A; Kashyap B; Dibyashree
Indian J Dermatol Venereol Leprol; 2024 May; ():1-5. PubMed ID: 38841938
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of TWEAK in patients with psoriasis vulgaris.
Bilgiç Ö; Sivrikaya A; Toker A; Ünlü A; Altınyazar C
Cytokine; 2016 Jan; 77():10-3. PubMed ID: 26499979
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokines and growth factor levels in Japanese patients with psoriasis.
Takahashi H; Tsuji H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2010 Aug; 35(6):645-9. PubMed ID: 19843085
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.
Elkamshoushi AM; Omar SS; El Abd AM; Hassan SZ; Sultan EA; Abd Elkawy E
Int J Dermatol; 2019 Apr; 58(4):456-464. PubMed ID: 30471086
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
Arican O; Aral M; Sasmaz S; Ciragil P
Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
[TBL] [Abstract][Full Text] [Related]
14. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
15. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
16. Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis.
Yilmaz SB; Cicek N; Coskun M; Yegin O; Alpsoy E
Arch Dermatol Res; 2012 Aug; 304(6):465-9. PubMed ID: 22426986
[TBL] [Abstract][Full Text] [Related]
17. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
Michalak-Stoma A; Bartosińska J; Kowal M; Juszkiewicz-Borowiec M; Gerkowicz A; Chodorowska G
Dis Markers; 2013; 35(6):625-31. PubMed ID: 24288431
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory versus anti-inflammatory cytokines in psoriatic patients (case-control study).
Elbana AM; Elgamal E; Hashim O; Emran TM; Alkhrsawy AA
J Cosmet Dermatol; 2022 Nov; 21(11):6302-6307. PubMed ID: 35869799
[TBL] [Abstract][Full Text] [Related]
20. Is there a correlation of serum and tissue T helper-1 and -2 cytokine profiles with psoriasis activity and severity? A cross-sectional study.
Khandpur S; Gupta V; Das D; Sharma A
Indian J Dermatol Venereol Leprol; 2018; 84(4):414-418. PubMed ID: 29491194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
